A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence.

Wu, Zhengquan; Uhl, Bernd; Gires, Olivier; Reichel, Christoph A

Wu, Zhengquan; Uhl, Bernd; Gires, Olivier; Reichel, Christoph A.

Afiliación

Wu Z; Department of Otorhinolaryngology, Ludwigs-Maximilians-University Medical Centre, Marchioninistr. 15, 81377, Munich, Germany.
Uhl B; Walter Brendel Centre of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.
Gires O; Department of Otorhinolaryngology, Ludwigs-Maximilians-University Medical Centre, Marchioninistr. 15, 81377, Munich, Germany.
Reichel CA; Walter Brendel Centre of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.

J Biomed Sci ; 30(1): 21, 2023 Mar 28.

Article en En | MEDLINE | ID: mdl-36978029

Asunto(s)

Neoplasias; Transcriptoma; Humanos; Neoplasias/genética; Neoplasias/terapia; Células Endoteliales; Medicina de Precisión; Inmunoterapia; Senescencia Celular; Endotelio; Pronóstico

Palabras clave

Endothelial cell senescence; Immunotherapy; Pan-cancer analysis; Prognosis; scRNA-seq

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transcriptoma / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Biomed Sci Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google